Medicine and Dentistry
Cohort Analysis
100%
Out of Hospital Cardiac Arrest
92%
Intensive Care Unit
73%
Resuscitation
47%
Venous Thromboembolism
46%
Nursing Home
46%
Return of Spontaneous Circulation
36%
Artificial Respiration
32%
Heart Arrest
30%
Diagnosis
28%
Defibrillation
24%
Cumulative Incidence
23%
Second Cancer
23%
Vasopressin
23%
Pneumonectomy
23%
Lobectomy
23%
Apoplexy
23%
Orthopedic Surgery
23%
Cohort Effect
23%
Randomized Clinical Trial
23%
Myocardial Infarction
23%
Placebo
23%
Respiration Depression
23%
Acute Heart Infarction
23%
Alcohol Consumption
23%
Lung Function
23%
Regional Anesthesia
23%
Vascular Surgery
23%
General Anesthesia
23%
Cardiovascular Disease
23%
Classical Hodgkin Lymphoma
23%
Cardiovascular System
20%
Diseases
17%
Renal Replacement Therapy
17%
SAPS II
15%
Proportional Hazards Model
14%
Odds Ratio
14%
Doxorubicin
11%
Hazard Ratio
9%
Wedge Resection
9%
Disease Severity
7%
Disability Pension
7%
Malignant Neoplasm
6%
Lung Cancer
6%
Cancer Types
6%
Attributable Risk
6%
Trendelenburg Position
5%
Intraoperative Period
5%
Charlson Comorbidity Index
5%
Patient Referral
5%
Keyphrases
Out-of-hospital Cardiac Arrest
69%
30-day Survival
39%
Survivors
36%
Return of Spontaneous Circulation
32%
Confidence Interval
27%
Intensive Care Unit
26%
Hospital Admission
26%
Nursing Homes
26%
In-hospital Cardiac Arrest
23%
Noninvasive Estimation
23%
Respiratory Depression
23%
Robot-assisted Laparoscopy
23%
Pneumonectomy
23%
Nursing Home Admission
23%
Organ Support
23%
Placebo
23%
Randomized Clinical Trial
23%
Diagnostic Support
23%
Lower Extremity Orthopedic Surgery
23%
Length of Admission
23%
Private Homes
23%
Methylprednisolone
23%
Vasopressin
23%
Length of Hospital Stay
23%
Bystander Intervention
23%
Exhaled Breath Biomarkers
23%
Anoxic Brain Injury
23%
Peripheral Vascular Surgery
23%
Cardiac Comorbidities
23%
Regional Anesthesia
23%
General Anesthesia
23%
Bystander CPR
19%
Bystander Defibrillation
16%
Pulmonary Function Parameters
15%
Vascular Surgery
15%
Placebo Groups
14%
Cardiopulmonary Resuscitation
13%
Intervention Group
11%
Odds Ratio
11%
30-day Mortality
11%
Anesthesia
11%
Bystander
9%
Intensive Care Unit Admission
9%
Nursing Home Residents
9%
ICU Stay
9%
Neurological Health
9%
Risk Difference
8%
Risk Ratio
8%
Cardiovascular Support
7%
U-shaped Curve
7%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Arrest
50%
Vasopressin
46%
Placebo
46%
Methylprednisolone
46%
Randomized Clinical Trial
46%
Out of Hospital Cardiac Arrest
46%
Cohort Study
28%
Disease
25%
Heart Failure
23%
Heart Infarction
23%
Chronic Lymphatic Leukemia
23%
Venous Thromboembolism
23%
Acute Heart Infarction
23%
Ethanol
23%
Psychotropic Agent
17%
Epinephrine
13%
Comorbidity
8%
Second Cancer
5%
Hospital Mortality
5%
Mortality Rate
5%
